Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-06-15-Speech-2-100"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100615.5.2-100"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, I would like to thank you for this lively and interesting debate which generated such strong views on many areas of the proposal. These views will, of course, be carefully considered by the Commission.
There are certain issues that we believe are fundamental for consumers – for example, availability of information on allergens on all food; front-of-pack nutrition labelling with endorsement of additional labelling by Member States; the inclusion of measurable criteria for legibility; and balanced information concerning consumer health. I would like to emphasise once again my strong support for the principle of nutrient profiles, and would stress that we will not be stopping the production of any food and that work on this will proceed in an open-minded manner. The Commission cannot accept deletion of this provision from the Claims Regulation.
I would like, if I may, to react to some of the issues that were raised here today. On the EFSA financing, I can say that we are working at the moment on a non-legislative report which should be ready after the summer and which will state what our direction will be in this regard.
On innovation, I believe that our proposals are not against innovation. I am in favour of innovation – as is the Commission – but it must be responsible innovation. We want innovation that works for the consumers and innovation that works for consumers’ health.
On the issue of the claims made and the approvals mentioned by Mr Davies, I must state that, under Article 13, we did have about 44 000 claims by Member States. When we asked Member States to revise these claims, they were reduced to 4 000. This indicates to me the lax and superficial way in which claims are made and why it is important that we control these claims that, as I have said, are made as a marketing tool to sell products. In fact, this process has been slightly delayed because of the volumes, but we are working on batches. The first batch has been completed by EFSA and is being reviewed by the Commission for publication, and the second batch is also well advanced at EFSA. This is an ongoing process. On the other hand, 50 claims have already been judged under Article 14, and the Commission has pronounced itself in favour or against. Work on this is therefore progressing – we have been delayed but the work is going on.
I would like to make another comment on the impact assessments. The Commission has supported this proposal with wide consultation of stakeholders and a terrain impact assessment weighing the cost and benefits of the various policy options. The impact of several amendments tabled by honourable Members today and in the past to add extra labelling requirements has not been subject to any assessment. For the sake of better regulation, I believe that impact assessment should underpin the decision-making process at all times.
I would like to end by again thanking Mrs Renate Sommer and all honourable Members for their contributions. A full listing of the Commission’s position on each of the amendments is, as usual, being made available to Parliament."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples